Clinical Trials · NCT00641056
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 467
- Start date
- Apr 2008
- Locations
- 75 sites, 16 countries
- Primary endpoint
- Change in HbA1c From Baseline to Week 26